Biocracked
Approach: the human outcome. Palette: bold color field.

A close, slightly high three-quarter view of a bare abdomen, cropped at the ribs and hips with no face. A hand in an electric green (#00e676) nitrile glove pinches a fold of belly skin and holds a slim syringe with the needle just about to enter. Faint yellow-purple bruising near the injection site hints at the side effects. The torso fills the frame against a flat, saturated teal backdrop that contrasts with the warm skin tones. Soft, even studio light from the left gives gentle shadows and visible skin texture, with fine pores and small hairs. The syringe tip is in sharp focus and the background falls away. No text or markings anywhere. The mood is clinical, unsentimental and skeptical.
Research

Apa CBL‑514 Tenan Ngobong Lemak? Kabeh Sing Kita Ngerti

Helix Ward · · 4 min read

Apa CBL‑514 Tenan Ngobong Lemak? Kabeh Sing Kita Ngerti

Cathetan penting: Ora iki saran medis. CBL‑514 isih eksperimental, durung disetujui FDA, lan ora ana ing bentuk suplemen.

Apa CBL‑514 iku (lan apa dudu)

CBL‑514 (bukan "CL‑514") yaiku molekul cilik sing disuntikaké langsung menyang jaringan lemak subkutan, utamané ing weteng. Iki dudu obat oral utawa produk konsumen sing bisa dituku ing toko. Struktur kimiané ora dirilis publik.

Mekanisme sing diajokaké yaiku lipolisis melalui apoptosis sel lemak (adiposit), dudu nambah laju metabolisme utawa "mbakar kalori". Klaim non‑klinis sadurungé, kalebu penghambatan DYRK1b lan up‑regulasi caspase‑3 serta Bax/Bcl‑2, asalé saka laporan perusahaan sing ora dipublikasikaké. Studi fase 2a sadurungé (Goodman dkk., 2022) cilik lan ora nganggo plasebo.

Referensi: Gold M, dkk. Aesthetic Surgery Journal. 2025;45(6):611‑620. Open access on PMC | PubMed | DOI | NCT04897412.

Desain Riset Singkat

  • Fase 2, randomisasi 2 : 1, single‑blind (peserta dibutaken; peneliti lan sponsor ora).
  • Kontrol: saline (plasebo).
  • Lokasi: lima pusat ing AS lan Australia, Februari 2022 – Maret 2023.
  • Protokol: maksimal 4 perawatan kanthi jarak 4 minggu, lan follow‑up 4 lan 8 minggu sawisé perawatan pungkasan. Saben perawatan nggunakake 25‑50 suntikan (2,4 mL, 2 mg/cm²), total nganti 600 mg.
  • Pengukuran lemak: ketebalan ultrasonik ing 4 titik ing wilayah seluas 300 cm².
  • Partisipan: 76 diacak (50 CBL‑514, 26 plasebo), 75 diperlakukan (49 lan 26).

Hasil Utama (ITT)

≥150 mL pengurangan lemak (endpoint utama)

Follow‑up CBL‑514 Plasebo P
4 minggu 63,9 % (23/36; 95 % CI 46,22–79,18) 17,4 % (4/23; 95 % CI 4,95–38,78) < 0,001
8 minggu 69,6 % (16/23; 95 % CI 47,08–86,79) 0 % (0/16) < 0,001

≥200 mL pengurangan lemak

  • 4 minggu: 58,3 % (21/36) vs 8,7 % (2/23), P < 0,001.
  • 8 minggu: 60,9 % (14/23) vs 0 % (0/16), P < 0,001.

Exploratory ≥250 mL

  • 4 minggu: 44,4 % (16/36)
  • 8 minggu: 52,2 % (12/23)
  • Plasebo: ora ana sing nggayuh.

Perubahan volume lemak (LS mean vs baseline)

  • CBL‑514: –199,80 mL (4 minggu) lan –209,46 mL (8 minggu) (P < 0,001).
  • Selisih antar‑kelompok: –206,62 mL (95 % CI –276,09 nganti –137,16) lan –216,28 mL (95 % CI –288,28 nganti –144,28).

Per‑protocol (n = 30)

  • –314,70 mL (4 minggu) lan –279,45 mL (8 minggu).
  • Selisih antar‑kelompok: –312,08 mL lan –276,83 mL.

Cathetan: Nilai paling gedhé sing kacathet yaiku pengurangan 750 mL ing siji partisipan CBL‑514. Iki kasus ekstrim, dudu rata‑rata.

Jumlah perawatan sing dibutuhake

  • Saka 28 partisipan CBL‑514 sing nggayuh ≥150 mL, 42,9 % (12) nyukupi target sawise siji perawatan, lan 35,7 % (10) sawise loro perawatan (total 78,6 %).
  • Ing grup per‑protocol, 44,4 % (8/18) sawise siji perawatan lan 27,8 % (5/18) sawise loro perawatan.

Cathetan Bobot Badan

Pengukuran iki mung babagan volume lemak regional, dudu oksidasi lemak sacara sistemik.

  • CBL‑514: rata‑rata bobot +0,45 kg (4 minggu) lan +0,02 kg (8 minggu).
  • Plasebo: rata‑rata bobot –0,76 kg (4 minggu) lan –0,26 kg (8 minggu).

Ora ana perbedaan signifikan ing bobot utawa BMI antar‑kelompok. Malah ana partisipan sing bobote nambah luwih saka 1 kg nanging tetep nggayuh target pengurangan lemak lokal.

Masalah Denominator

Saka 75 sing diperlakukan, mung 38 sing ngrampungake studi (49,3 % dropout). Penyebab:

  • Loss to follow‑up: 6
  • Withdrawal peserta: 7
  • Instabilitas bobot: 7
  • Non‑adherence jadwal: 6
  • Adverse events: 4

Akibat dropout, denominator CBL‑514 mudhun saka 36 dadi 23, lan plasebo saka 23 dadi 16 ing minggu ke‑8. Persentase iki kudu dipahami kanthi konteks sampel sing cilik lan interval kepercayaan sing amba.

Gambar lan Ultrasonik: Anekdot

Makalah nyedhiyakake foto loro wanita (umur 49 lan 46 tahun). Pengurangan volume lemak yaiku 40,85 % – 47,37 %, nanging bobot awak mung turun kurang saka 1 kg. Ing wanita umur 46 tahun, ketebalan ultrasonik ing patang titik mudhun saka 4,06‑4,20‑3,90‑3,26 cm dadi kira‑kira 2 cm utawa kurang. Overlay 3‑dimensi nuduhaké area sing tetep entuk pengurangan lemak. Penulis nyatakake ora ana utawa sithik kendur kulit, nanging iki penilaian visual, dudu endpoint formal.

Keamanan: Umum lan Mayoritas Lokal

Kebanyakan partisipan ngalami treatment‑emergent adverse events (TEAE), kalebu grup plasebo, kanthi rate 98‑100 %.

Reaksi situs suntikan (tabel):

  • Discoloration: 71,4 % (CBL‑514) vs 11,5 % (plasebo)
  • Induration: 61,2 % vs 7,7 %
  • Severe pain: 18,4 % vs 0 %

Rincian tingkat keparahan, panggunaan analgesik, lan wektu resolusi dicantumake; mayoritas reaksi mari sajrone seminggu. Rong partisipan mandheg amarga kejadian sing terkait perawatan. Siji kasus hiperlipidemia dianggep mungkin terkait. Siji kejadian serius — metastasis peritoneal — dinilai ora terkait. Ora ana laporan nekrosis kulit, ulkus, utawa cedera saraf.

Perbandingan karo Metode Liyane

Penulis nyebutake studi cryolipolysis sing nggunakake cara ngukur beda. Salah siji laporan nyebutake rata‑rata pengurangan 264,8 mL ing weteng lan flank sawisé 12 minggu (hingga 24 siklus). Laporan liya nyebutake pengurangan 39,6 mL ing flank sawisé 2 bulan saka siji siklus. Penulis nggambaraké tren CBL‑514 "kedengarane luwih gedhé" lan nyatakake asil "padha karo sing dicapai karo liposuction". Nanging, uji coba iki ora duwe grup pembanding langsung karo cryolipolysis utawa liposuction.

Keterbatasan

  • Fase 2 karo follow‑up mung 8 minggu.
  • Desain single‑blind; peneliti ora dibutaken.
  • Sponsor melu ing desain, analisis, nulis, lan keputusan publikasi.
  • Dropout tinggi lan grup per‑protocol cilik.
  • Demografi miring: 94 % wanita ing grup CBL‑514, 86 % kulit putih.
  • Pengukuran ultrasonik adhedhasar rumus kuboid, dudu pengukuran lemak langsung.
  • Ora ana penyesuaian kanggo multipel testing.

Kesimpulan

CBL‑514 bisa ngurangi volume lemak subkutan ing weteng sing diukur kanthi ultrasonik luwih akeh tinimbang saline, kanthi efek sing gedhé lan statistik signifikan. Nanging, ora ana penurunan bobot awak, lan bukti ora ndhukung pembakaran lemak sistemik. Kasil iki kudu dibukak maneh nganggo uji coba sing luwih gedhé, periode luwih dawa, lan replikasi independen. Saiki, CBL‑514 tetep eksperimental lan ora dadi pilihan pengobatan standar.

Original study

Read the original research on pmc.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

HW

Written by

Helix Ward

Helix Ward writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 1, macro science, with Palette D, bold color field.

Extreme close-up microscopy-style photograph of a cluster of adipocytes (fat cells). Each is a translucent, pale yellow sphere with a thin membrane, and a few are shrunken and crinkled to suggest apoptosis. The cells sit against a saturated magenta backdrop. The camera is slightly above, at a shallow 30-degree angle, with a very shallow depth of field so the foreground cells are razor sharp and the rest melts into soft bokeh. Hard, clean side light from the left makes the membranes glisten and casts crisp magenta-tinted shadows. One tiny electric green fluorescent speck glows inside a single collapsing cell as a subtle accent. The mood is precise, clinical and curious, with a bold editorial feel. There is no text and no blue cast.
research

Injeksi Lipolisis CBL-514: Peta Bukti Fase II

BY DR. SYNAPSE ·

CBL-514 yaiku suntikan molekul cilik sing lagi diteliti supaya sel lemak (adiposit) ngalami apoptosis lan njalari pangurangan kantong lemak ing weteng. Ing uji fase II sing dilakokaké ing taun 2025 kanthi 76 peserta acak, volume lemak sing diukur nganggo ultrasound nyusut drastis dibandhingake karo saline, nanging bobot awak ora owah. Tulisan iki nerangake desain, dosis 2 mg/cm², data efektifitas lengkap karo denominator sing saya cilik, lan mekanisme DYRK1b‑caspase sing dilaporaké perusahaan. Nanging uga disorot watesan penting: desain siji‑blind, peran sponsor, attrisi 49 %, follow‑up sing cekak, lan mayoritas partisipan wanita.

**Approach 1 (macro science), Palette D (bold color field).**

Extreme close-up microscopy-style photograph of a cluster of fat cells (adipocytes), rendered as translucent, pearly spheres with thin membranes and tiny lipid droplets inside. One cell in the center is visibly shrinking and blebbing, its membrane crinkled and fragmenting into small beads, the look of apoptosis. A few of the surrounding cells are intact and glossy. The cells sit against a saturated tomato-red backdrop, so the pale yellow-cream spheres stand out sharply. The camera looks straight down at shallow depth of field, with the focal plane on the dying cell and the edges softly blurred. Soft, diffuse top light gives gentle highlights and warm shadows, with no blue cast. One thin electric green fluorescent ring around the central cell's nucleus is the only green accent. The mood is analytical, precise and quietly skeptical.
research

Kepiye Cara Kerja CBL-514? Iki Ilmu Penjenengané

BY DR. SYNAPSE ·

CBL-514 ora dianggep minangka obat sing nglebur lemak. Klaimé ngganggu sinyal urip sel lemak lan nyurung sel kasebut mlebu proses apoptosis liwat DYRK1b, caspase‑3 lan Bax/Bcl‑2. Buktine asalé saka laporan perusahaan sing durung dipublikasikaké, dene struktur kimiane ora diwartakake. Uji fase 2 taun 2025 mung ngukur volume lemak nganggo ultrasonik lan foto, tanpa biopsi utawa data caspase. Artikel iki misahaké hipotesis molekuler saka apa sing saktenané diukur ing manungsa, kalebu tingkat dropout sing dhuwur lan rancangan single‑blind.

Approach 2, lab in action, with palette D, bold color field.

Straight-on, slightly elevated close shot of a gloved hand in a pale nitrile glove holding a glass syringe with a fine needle. The syringe is filled with clear liquid and sits over a row of small glass vials in a matte white rack. The whole scene sits against a saturated tomato-red seamless backdrop. Soft, even studio light gives crisp highlights along the syringe barrel and the vial glass, plus gentle warm-red reflections on the surfaces. A thin electric green (#00e676) cap on one vial is the only small accent. The dosing markings on the syringe are blurred and unreadable. Shallow depth of field blurs the back vials into soft shapes. The mood is precise, clinical and investigational, with high contrast and a measured, careful feel. No text, no labels, no logos.
research

Dosis CBL‑514 – Apa sing Dikatakan Ilmu?

BY DR. SYNAPSE ·

Trial CBL‑514 iku protokol injeksi investigasional, lan angka “600 mg” iku wates maksimum saben perawatan, dudu dosis suplemen. Artikel iki nerangaké studi fase 2a sing nggolèki dosis (1,2, 1,6, lan 2,0 mg/cm² ing area 150 cm², n=43, open‑label) lan nerangaké asal‑usul angka 24,96 % sing asring disebut. Banjur dibahas fase 2 kanthi kontrol plasebo, sing tetep nganggo 2,0 mg/cm² nanging nambah area dadi 300 cm² lan wates dadi 600 mg. Sampeyan bakal ngerti kenapa total mg ora bisa dibandhingaké antarane studi, apa sing dilaporaké babagan keamanan, lan kenapa iki isih ora disetujui utawa dadi saran.

Approach 1, macro science, in palette D, bold color field.

Extreme close-up photograph of a cluster of fat cells (adipocytes) in tissue, shot like a stained microscopy image. Rounded, translucent, pearly-yellow lipid-filled cells press together in a honeycomb. Several in the center look collapsed and shriveled, with ruptured membranes and scattered droplets. A few fine threads of electric green (#00e676) fluorescent stain outline the cell walls. The camera is straight-on at shallow depth of field, with the background cells melting into soft blur. Bright, even transmitted light makes the membranes glow. The backdrop is a saturated magenta-to-tomato-red field that sets off the pale yellow cells. The mood is scrutinizing, skeptical and precise. No text, no labels.
research

Injeksi Penghilangan Lemak CBL-514: Apa Kata Ilmu?

BY DR. SYNAPSE ·

CBL-514 saiki wis liwat uji coba acak fase 2 sing dikontrol plasebo lan diterbitaké ing *Aesthetic Surgery Journal*. Penulis nglaporaké yèn uji iki nyukupi titik akhir utama lan sekunder, nanging desainé duwé akèh kekurangan: mung siji‑blind, sponsor melu ngrancang, nganalisa, lan nulis studi, lan tingkat drop‑out meh separo. Saka 75 peserta sing mlebu, mung 38 sing rampung, lan populasi sing diteliti mayoritas wanita lan kulit putih. Ing ngisor iki apa sing bisa didhukung uji iki, apa sing ora, lan kenapa iki dudu saran medis utawa bukti perawatan sing wis disetujui.

This page is available in